| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |